Published in Pediatr Nephrol on November 18, 2006
Atherosclerosis risk factors in young patients formerly treated for idiopathic nephrotic syndrome. Pediatr Nephrol (2008) 0.82
Subclinical cardiovascular disease and its association with risk factors in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol (2013) 0.77
Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem (2001) 3.17
Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med (2002) 2.70
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem (2001) 2.06
Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis (1993) 1.87
Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem (2000) 1.74
C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol Res (2004) 1.56
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther (2006) 1.48
High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J (2004) 1.43
High sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertens (2003) 1.27
C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem (2004) 1.21
The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int (1993) 1.21
The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol (2003) 1.11
High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. J Card Fail (2006) 1.09
High-sensitivity C-reactive protein concentration in a healthy Brazilian population. Int J Cardiol (2004) 0.89
C-reactive protein in end-stage renal disease: are there reasons to measure it? Blood Purif (2005) 0.89
C-reactive protein frequently localizes in the kidney in glomerular diseases. Clin Nephrol (2001) 0.86
Renal hemodynamics and sodium handling in moderate renal insufficiency: the role of insulin resistance and dyslipidemia. J Am Soc Nephrol (1995) 0.85
Reversibility of chronic cyclosporine nephropathy in rats after withdrawal of cyclosporine. Am J Physiol Renal Physiol (2002) 0.82
Vascular function of the peripheral circulation in patients with nephrosis. Kidney Int (2001) 0.81
C-reactive protein--an indicator of generalized bacterial infection in children with nephrotic syndrome. Acta Paediatr Scand (1986) 0.78
[Increase in C-reactive protein plasma levels during diabetes in infants and young adults]. Presse Med (2005) 0.78
Distribution of C-reactive protein and its relation to arterial hypertension in a country representing a high-risk region for cardiovascular diseases. Blood Press (2006) 0.78
Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Invest (2006) 0.77
Markers of systemic inflammation in children with hyperuricemia. Acta Paediatr (2012) 1.48
Assessment of lithogenic risk in children based on a morning spot urine sample. J Urol (2010) 1.45
KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatr Nephrol (2011) 1.23
Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol (2010) 1.11
A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index. Pediatr Nephrol (2008) 0.92
Hypertension in dialysed children: the prevalence and therapeutic approach in Poland--a nationwide survey. Nephrol Dial Transplant (2005) 0.91
MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children. Pediatr Nephrol (2006) 0.90
Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children. Pediatr Nephrol (2007) 0.89
Effect of cyclosporin A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr (2010) 0.86
Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old. Arch Med Sci (2012) 0.83
Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis. World J Gastroenterol (2005) 0.81
Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scand J Urol Nephrol (2010) 0.81
Response to prednisone in relation to NR3C1 intron B polymorphisms in childhood nephrotic syndrome. Pediatr Nephrol (2008) 0.81
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children. Pediatr Nephrol (2010) 0.81
Evaluation of bladder instability in children with recurrent urinary tract infections. Med Sci Monit (2002) 0.81
Assessment of serum cystatin C in children with congenital solitary kidney. Pediatr Nephrol (2006) 0.81
A potential pathogenic role of oxalate in autism. Eur J Paediatr Neurol (2011) 0.80
Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol (2003) 0.80
Iron Status and Inflammation in Early Stages of Chronic Kidney Disease. Kidney Blood Press Res (2015) 0.80
Retinol binding protein status in relation to ocular surface changes in patients with cystic fibrosis treated with daily vitamin A supplements. Eur J Pediatr (2004) 0.80
Expression of P-glycoprotein in lymphocytes from children with nephrotic syndrome, depending on their steroid response. Pediatr Nephrol (2006) 0.79
Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis. Scand J Urol Nephrol (2005) 0.79
[Analysis of serum levels of ghrelin and obestatin in children and adolescents with autoimmune thyroid diseases]. Pediatr Endocrinol Diabetes Metab (2009) 0.78
Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents? Scand J Urol Nephrol (2011) 0.78
A need to establish normative data for plasma oxalates. Am J Kidney Dis (2008) 0.78
Reference values of plasma oxalate in children and adolescents. Pediatr Nephrol (2008) 0.78
Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome. Acta Paediatr (2006) 0.78
[Serum and urinary homocysteine in children with steroid-dependent nephrotic syndrome]. Pol Merkur Lekarski (2011) 0.77
[WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report]. Pol Merkur Lekarski (2009) 0.77
Urinary transforming growth factor beta1 in children and adolescents with congenital solitary kidney. Pediatr Nephrol (2008) 0.76
Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux. Pediatr Nephrol (2008) 0.76
[Chronic peritoneal dialysis in infants--preliminary results of the multicenter survey]. Przegl Lek (2006) 0.76
Serum cystatin C concentration does not predict advanced liver disease in children with chronic hepatitis B. Clin Chim Acta (2004) 0.76
Expression of glucocorticoid receptors in nephrotic children depending on total prednisone dose. J Pediatr Endocrinol Metab (2005) 0.75
Serum and urine leptin concentration in children with nephrotic syndrome. Pediatr Nephrol (2005) 0.75
The diagnostic power of direct carbohydrate-deficient transferrin immunoassay in alcoholics. Absolute or relative values? Alcohol (2011) 0.75
Urinary MMP-9/NGAL ratio as a potential marker of FSGS in nephrotic children. Dis Markers (2013) 0.75
IgA nephropathy in a girl with psoriasis and seronegative arthritis. Pediatr Dermatol (2008) 0.75
[Evaluation of inflammatory and renal injury markers in youngest children with pyelonephritis]. Pol Merkur Lekarski (2008) 0.75
[Seasonal changes in serum level of eosinophil-derived neurotoxin, interleukin-18, and interferon-gamma in pollinosis patients]. Pol Merkur Lekarski (2005) 0.75
High-sensitivity C-reactive protein and mean platelet volume in paediatric hypertension. Pediatr Nephrol (2010) 0.75
Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A. Acta Paediatr (2006) 0.75
Serum and urine fibronectin levels in children with vesicoureteral reflux. Pediatr Nephrol (2007) 0.75
Spontaneous urinary calcium oxalate crystallization in hypercalciuric children. Pediatr Nephrol (2009) 0.75
[The concentration of plasma anion oxalate in children treatment antibiotics beta lactame]. Pol Merkur Lekarski (2006) 0.75
[Assessment of transforming growth factor-beta1 in serum of children with idiopathic nephrotic syndrome depending on the way of treatment]. Pol Merkur Lekarski (2003) 0.75
[Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology]. Przegl Lek (2009) 0.75
[Subclasses of immunoglobulin G in children with atopic bronchial asthma]. Pol Merkur Lekarski (2004) 0.75
Expression of multidrug resistance P-glycoprotein on lymphocytes from nephrotic children treated with cyclosporine A and ACE-inhibitor. Eur J Pediatr (2006) 0.75
[Reference values of 24-hour ambulatory blood pressure in healthy children by height]. Pol Merkur Lekarski (2004) 0.75
[The evaluation of urinary tract dysfunction in children with monosymptomatic primary nocturnal enuresis]. Pol Merkur Lekarski (2008) 0.75
[Analysis of vesicoureteral reflux (VUR) course in children]. Pol Merkur Lekarski (2008) 0.75
[Urinary laminin and fibronectin level in children with nephritic syndrome]. Pol Merkur Lekarski (2009) 0.75
[The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Pol Merkur Lekarski (2005) 0.75
[Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in the urine of children with pyelonephritis]. Pol Merkur Lekarski (2009) 0.75
[Assessment of 24-hour blood pressure function of the single kidney in children with renal agenesis]. Pol Merkur Lekarski (2005) 0.75
[Serum and urinary concentration of selected metalloproteinases and their tissue inhibitors in children with vesicoureteral reflux]. Pol Merkur Lekarski (2010) 0.75
Serum sialic acid as a marker of pancreatic cancers. Clin Lab (2013) 0.75
[Urinary TGF-beta1 excretion in children with renal cysts]. Przegl Lek (2006) 0.75